Evolving Biotechnologies with Olga Troya...

Daisy Wolf speaks with Dr. Andrew Huberman, professor of neurobiology and ophthalmology at Stanford University and host of the Huberman Lab podcast. They discuss how the pandemic sparked a consumer health revolution, the emerging peptide and GLP landscape, what the science actual ... Show More

a16z Partners Daisy Wolf and Eva Steinman talk with Zach Cohen and Raymond Wang, cofounders of Ease Health, a company building an AI operating system for behavioral health that combines CRM, EHR, and revenue cycle management into a single platform. They discuss why behavioral hea ... Show More

At the Oliver Wyman Health Innovation Summit 2025, Julie Yoo, General Partner at a16z Bio + Health, makes the case that healthcare is uniquely positioned to benefit from AI more than any other industry. She argues that healthcare's historical underinvestment in technology is now ... Show More

<p>In this episode, vanguard geneticist <a href='https://wyss.harvard.edu/team/core-faculty/george-church/'>Dr. George Church</a> recounts his storied career from his early fascination with computers and science to his pioneering work in genomics and synthetic biology. Dr. Church ... Show More

<p>Kevin Hrusovsky, CEO of Quanterix and the Powering Precision Health Summit founder, joins me on the Tech Talks Daily Podcast. Kevin has more than 25 years of experience leading life sciences and biotechnology companies and believes that accelerating precision medicine is the k ... Show More

"We've been promised a future of chrome -- but what if the future is fleshy?" asks biological designer Christina Agapakis. In this awe-inspiring talk, Agapakis details her work in synthetic biology -- a multidisciplinary area of research that pokes holes in the line between what' ... Show More

"We've been promised a future of chrome -- but what if the future is fleshy?" asks biological designer Christina Agapakis. In this awe-inspiring talk, Agapakis details her work in synthetic biology -- a multidisciplinary area of research that pokes holes in the line between what' ... Show More

"We've been promised a future of chrome -- but what if the future is fleshy?" asks biological designer Christina Agapakis. In this awe-inspiring talk, Agapakis details her work in synthetic biology -- a multidisciplinary area of research that pokes holes in the line between what' ... Show More

In the decade since the genome editing capabilities of CRISPR-Cas9 emerged, research into novel medicines has boomed – but alongside progress comes new ethical considerations. Controversy erupted in 2018, when Chinese scientist He Jiankui created the first babies with edited geno ... Show More

Cours du 14 février 2007 - 2ème heureCollège de FranceLa biotechnologie va permettre dans l'avenir d'améliorer considérablement le traitement des malades. Elle va permettre d'augmenter l'espérance de vie. Mais cette industrie devra résoudre certains problèmes éthiques comme le cl ... Show More

<p>In this episode of the AI Grand Rounds podcast, <a href='https://www.insitro.com/leadership/daphne-koller/'>Dr. Daphne Koller</a> charts her professional trajectory, tracing her early fascination with computers to her influential role in AI and health care. Initially intrigued ... Show More